Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
skin hypersensitivity along his left trunk wrapping from front to back; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of hypersensitive skin in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 03-OCT-2025, the patient received the 2nd dose of Shingrix. On 13-OCT-2025, 10 days after receiving Shingrix, the patient experienced hypersensitive skin (Verbatim: skin hypersensitivity along his left trunk wrapping from front to back). The outcome of the hypersensitive skin was not resolved. It was unknown if the reporter considered the hypersensitive skin to be related to Shingrix. It was unknown if the company considered the hypersensitive skin to be related to Shingrix. Additional Information: GSK Receipt Date: 22-OCT-2025 The patient received second Shingrix dose on 03-OCT-2025. Ten days after vaccination, on 13-OCT-2025, the patient developed skin hypersensitivity along his left trunk wrapping from front to back. The hypersensitivity continued. The patient would see his physician today. No other information was reported. The batch number was not provided and a request for this information has been made.